F.L. Putnam Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68.1M | Buy |
74,082
+17,797
| +32% | +$18M | 1.01% | 21 |
|
|
2025
Q4 | $60.5M | Buy |
56,285
+2,471
| +5% | +$2.36M | 0.88% | 22 |
|
|
2025
Q3 | $41.1M | Buy |
53,814
+27,447
| +104% | +$20.4M | 0.61% | 30 |
|
|
2025
Q2 | $20.6M | Sell |
26,367
-9,401
| -26% | -$7.31M | 0.35% | 58 |
|
|
2025
Q1 | $29.5M | Buy |
35,768
+328
| +0.9% | +$273K | 0.55% | 38 |
|
|
2024
Q4 | $27.4M | Sell |
35,440
-3,870
| -10% | -$3.2M | 0.5% | 43 |
|
|
2024
Q3 | $29.3M | Buy |
39,310
+5,938
| +18% | +$5.34M | 0.53% | 40 |
|
|
2024
Q2 | $30.2M | Buy |
33,372
+3,104
| +10% | +$2.48M | 0.57% | 35 |
|
|
2024
Q1 | $23.5M | Sell |
30,268
-563
| -2% | -$401K | 0.5% | 44 |
|
|
2023
Q4 | $18M | Sell |
30,831
-352
| -1% | -$205K | 0.42% | 55 |
|
|
2023
Q3 | $16.7M | Sell |
31,183
-3,690
| -11% | -$1.9M | 0.46% | 49 |
|
|
2023
Q2 | $16.4M | Buy |
34,873
+2,570
| +8% | +$1.08M | 0.45% | 51 |
|
|
2023
Q1 | $11.1M | Sell |
32,303
-2,409
| -7% | -$812K | 0.36% | 65 |
|
|
2022
Q4 | $12.7M | Sell |
34,712
-709
| -2% | -$251K | 0.46% | 56 |
|
|
2022
Q3 | $11.5M | Buy |
35,421
+627
| +2% | +$199K | 0.45% | 51 |
|
|
2022
Q2 | $11.3M | Buy |
34,794
+2,161
| +7% | +$649K | 0.41% | 57 |
|
|
2022
Q1 | $9.35M | Buy |
32,633
+2,547
| +8% | +$655K | 0.3% | 72 |
|
|
2021
Q4 | $8.31M | Buy |
30,086
+11,461
| +62% | +$2.91M | 0.25% | 79 |
|
|
2021
Q3 | $4.3M | Buy |
18,625
+111
| +0.6% | +$27.4K | 0.15% | 117 |
|
|
2021
Q2 | $4.25M | Buy |
18,514
+7,948
| +75% | +$1.6M | 0.15% | 120 |
|
|
2021
Q1 | $1.97M | Sell |
10,566
-220
| -2% | -$43K | 0.09% | 144 |
|
|
2020
Q4 | $1.82M | Sell |
10,786
-18,246
| -63% | -$2.72M | 0.09% | 136 |
|
|
2020
Q3 | $4.3M | Sell |
29,032
-678
| -2% | -$105K | 0.24% | 84 |
|
|
2020
Q2 | $4.88M | Buy |
29,710
+2,964
| +11% | +$455K | 0.29% | 79 |
|
|
2020
Q1 | $3.71M | Buy |
26,746
+1,893
| +8% | +$260K | 0.28% | 84 |
|
|
2019
Q4 | $3.27M | Sell |
24,853
-8,657
| -26% | -$1M | 0.2% | 104 |
|
|
2019
Q3 | $3.75M | Buy |
33,510
+2,439
| +8% | +$272K | 0.26% | 92 |
|
|
2019
Q2 | $3.44M | Buy |
31,071
+7,656
| +33% | +$902K | 0.28% | 90 |
|
|
2019
Q1 | $3.04M | Buy |
23,415
+8,346
| +55% | +$1.01M | 0.26% | 94 |
|
|
2018
Q4 | $1.74M | Buy |
15,069
+12,734
| +545% | +$1.42M | 0.19% | 101 |
|
|
2018
Q3 | $251K | Buy |
+2,335
| New | +$233K | 0.02% | 200 |
|
|
2018
Q2 | – | Sell |
-5,105
| Closed | -$395K | – | 228 |
|
|
2018
Q1 | $395K | Sell |
5,105
-26,941
| -84% | -$2.17M | 0.04% | 193 |
|
|
2017
Q4 | $2.71M | Buy |
32,046
+5,877
| +22% | +$500K | 0.25% | 96 |
|
|
2017
Q3 | $2.24M | Buy |
+26,169
| New | +$2.15M | 0.21% | 99 |
|
|
2017
Q1 | $1.77M | Buy |
21,076
+5,778
| +38% | +$463K | 0.18% | 109 |
|
|
2016
Q4 | $1.13M | Sell |
15,298
-6,990
| -31% | -$521K | 0.13% | 112 |
|
|
2016
Q3 | $1.79M | Buy |
+22,288
| New | +$1.78M | 0.2% | 87 |
|
|
2016
Q1 | – | Sell |
-2,505
| Closed | -$211K | – | 173 |
|
|
2015
Q4 | $211K | Buy |
+2,505
| New | +$208K | 0.02% | 163 |
|
|
2013
Q4 | – | Sell |
-46,219
| Closed | -$2.33M | – | 202 |
|
|
2013
Q3 | $2.33M | Sell |
46,219
-266
| -0.6% | -$13.9K | 0.31% | 95 |
|
|
2013
Q2 | $2.28M | Buy |
+46,485
| New | +$2.53M | 0.33% | 95 |
|
Other funds holding LLY
VCM
VPM
F.L. Putnam Investment Management's LLY Position: Q1 2026 in Review
F.L. Putnam Investment Management increased its Eli Lilly (LLY) stake by 32% in Q1 2026, buying an estimated $18M and bringing the position to 74,082 shares worth $68.1M. The position accounts for 1.01% of the portfolio, ranked #21.
F.L. Putnam Investment Management first reported a position in LLY in Q2 2013 and has held it in 40 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- F.L. Putnam Investment Management held 74,082 shares of Eli Lilly worth $68.1M as of Q1 2026.
- F.L. Putnam Investment Management bought 17,797 Eli Lilly shares in Q1 2026, an estimated $18M.
- Eli Lilly made up 1.01% of F.L. Putnam Investment Management's portfolio in Q1 2026, its #21 holding.
- F.L. Putnam Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 40 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on F.L. Putnam Investment Management's 13F filing for Q1 2026, filed 5 May 2026.